In summary, Cystatin C represents a very sensitive and specific biomarker to predict AKI in patients under-going thoracic surgery with MHCA even before surgery, whereas the predictive capacity of [TIMP-2]*[IGFBP7] is only moderate. The gene discussed is TIMP2; the disease is acute kidney injury.